Metropolis Healthcare Limited (NSE:METROPOLIS)
India flag India · Delayed Price · Currency is INR
536.10
+6.85 (1.29%)
Oct 12, 2026, 3:29 PM IST

Metropolis Healthcare Stock Forecast

Stock Price Forecast

According to 19 analysts polled by S&P Global, Metropolis Healthcare stock has a consensus rating of "Buy" and an average price target of ₹663.68. The average 1-year stock price forecast is 23.80% higher than the current stock price, while the lowest is ₹550.00 (+2.59%) and the highest is ₹760.00 (+41.76%).

Price Target: ₹663.68 (+23.80%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹550.00₹663.68₹670.00₹760.00
Change+2.59%+23.80%+24.98%+41.76%

Analyst Ratings

The average analyst rating for Metropolis Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jul '26Aug '26Sep '26Oct '26
Strong Buy101011111111
Buy444444
Hold222222
Sell000000
Strong Sell222222
Total181819191919

Financial Forecast

Revenue This Year
19.08B
from 16.46B
Increased by 15.90%
Revenue Next Year
21.88B
from 19.08B
Increased by 14.68%
EPS This Year
12.43
from 9.51
Increased by 30.67%
EPS Next Year
15.51
from 12.43
Increased by 24.82%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
12.28B11.48B12.08B13.31B16.46B19.08B
Revenue Growth
23.08%-6.52%5.18%10.23%23.64%15.90%
Gross Profit
9.31B8.74B9.38B10.28B12.73B15.30B
Gross Margin
75.77%76.13%77.65%77.24%77.36%80.20%
Operating Income
2.82B2.04B1.95B1.94B2.68B3.44B
Net Income
2.14B1.43B1.28B1.45B1.90B2.58B
EPS
----9.5112.43
EPS Growth
----35.14%30.67%
Forward PE
43.7136.6651.5538.8037.3443.14
Dividend / Share
2.002.001.00-2.002.69
Dividend Growth
---50.00%--34.36%
Free Cash Flow
----3.07B3.02B
No. Analysts
-----19
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High19.6B
Avg19.1B
Low18.8B

Revenue Growth

Revenue Growth202720282029
High
19.3%
Avg
15.9%
Low
14.5%

EPS Forecast

EPS202720282029
High13.20
Avg12.43
Low12.00

EPS Growth

EPS Growth202720282029
High
38.8%
Avg
30.7%
Low
26.2%